- Home
- EMX vs CADL Comparison
EMX vs CADL Comparison
Compare EMX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMX
- CADL
- Stock Information
- Founded
- EMX N/A
- CADL 1999
- Country
- EMX Canada
- CADL United States
- Employees
- EMX N/A
- CADL N/A
- Industry
- EMX
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- EMX
- CADL Health Care
- Exchange
- EMX Nasdaq
- CADL Nasdaq
- Market Cap
- EMX 338.0M
- CADL 313.5M
- IPO Year
- EMX N/A
- CADL 2021
- Fundamental
- Price
- EMX $4.08
- CADL $5.00
- Analyst Decision
- EMX Strong Buy
- CADL Strong Buy
- Analyst Count
- EMX 2
- CADL 5
- Target Price
- EMX $5.38
- CADL $19.80
- AVG Volume (30 Days)
- EMX 708.4K
- CADL 717.1K
- Earning Date
- EMX 11-06-2025
- CADL 08-14-2025
- Dividend Yield
- EMX N/A
- CADL N/A
- EPS Growth
- EMX N/A
- CADL N/A
- EPS
- EMX 0.04
- CADL N/A
- Revenue
- EMX $29,864,000.00
- CADL N/A
- Revenue This Year
- EMX $11.08
- CADL N/A
- Revenue Next Year
- EMX $3.72
- CADL N/A
- P/E Ratio
- EMX $91.28
- CADL N/A
- Revenue Growth
- EMX N/A
- CADL N/A
- 52 Week Low
- EMX $1.59
- CADL $3.79
- 52 Week High
- EMX $4.12
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- EMX 79.62
- CADL 34.03
- Support Level
- EMX $3.76
- CADL $5.70
- Resistance Level
- EMX $3.95
- CADL $6.04
- Average True Range (ATR)
- EMX 0.15
- CADL 0.32
- MACD
- EMX 0.06
- CADL -0.10
- Stochastic Oscillator
- EMX 96.31
- CADL 12.64
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.